ArticleLung India : official organ of Indian Chest Society
What is the true burden of chronic obstructive pulmonary disease in India and what are its implications at a national level?
Article in Lung India : official organ of Indian Chest Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Effectiveness and Safety of Glycopyrronium-Formoterol-Budesonide Triple Therapy in Chronic Obstructive Pulmonary Disease (AIR-FORCE): An Open-Label Multi-Centric Phase 4 Study.Advances in respiratory medicine · 2025Trial
- Article
- Study Protocol - Assessing the feasibility of 'Screening by Accredited Social Health Activist (ASHAs) and diagnosis by Community Health officers of Asthma and COPD at the primary health care System- A Novel Strategy-Frontiers in health services · 2026Article
- Outcomes and Usability of Formoterol-Budesonide Delivered Through SynchrobreatheDrugs - real world outcomes · 2025Article
- Exploring the possibility of a predictable precision therapy of COPD with inclusion of glycopyrronium responsiveness: A real-world experience.Lung India : official organ of Indian Chest Society · 2025Article
- Application of Artificial Intelligence in the Interpretation of Pulmonary Function Tests.Cureus · 2025Article
- Linking smoking with pulmonary function among COPD patients in India.Bioinformation · 2025Article
- GST polymorphism as a predictive biomarker for modulating the susceptibility to chronic obstructive pulmonary disease: A North Indian study.Experimental physiology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.